3-Methyl-5-(trichloromethyl)-1,2,4-oxadiazole → (R,R)-2-(tert-Butyloxycarbonyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-2,5-diazabicyclo[2.2.1]heptane
反応式
[CH3:1][C:2]1[N:6]=[C:5](C(Cl)(Cl)Cl)[O:4][N:3]=1.[C:11]([O:15][C:16]([N:18]1[CH2:23][C@H:22]2[CH2:24][C@@H:19]1[CH2:20][NH:21]2)=[O:17])([CH3:14])([CH3:13])[CH3:12]>C1(C)C=CC=CC=1>[C:11]([O:15][C:16]([N:18]1[CH2:23][C@H:22]2[CH2:24][C@@H:19]1[CH2:20][N:21]2[C:5]1[O:4][N:3]=[C:2]([CH3:1])[N:6]=1)=[O:17])([CH3:14])([CH3:12])[CH3:13]参加物
4
実験手順
A solution of 1.06 g of 3-methyl-5-trichloromethyl-1,2,4-oxadiazole prepared by the procedure of F. Eloy, Bull. Soc. Chim. Belg., 1964, 73, 793, in 2 ml of toluene is added slowly to a solution of 1.05 g of product from Example 1 and 0.82 g of diazabicyclo[3.6.0]unodecene-5 in 1 ml of toluene. The resulting mixture is stirred at room temperature for 3 days and then concentrated in vacuo to dryness. The residue is purified by chromatography (aluminum oxide, Activity Grade 2.5; methylene chloride) to give 0.74 g of the desired product as an off-white solid: